SEC SCHEDULE 13G

Company

HAEMONETICS CORP

Filed

April 8, 2022

Accession Number

0001422848-22-000229

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →